IMMNOV · Immunovia AB (publ) · Investor Relations
Market Cap
41.30M SEK
Shares
672.67M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-04 00:00 UTC | Interim report Q3 | Results publication |
| 2027-02-10 00:00 UTC | Year-end report 2026 | Results publication |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-06 | Interim report Q2 | Results publication |
| 2026-05-13 | Annual General Meeting | Shareholder meeting |
| 2026-05-07 | Interim report Q1 | Results publication |
| 2026-02-24 | Year-end report 2025 | Results publication |
| 2025-11-26 | Interim report Q3 | Event |
| 2025-08-28 | Interim report Q2 | Event |
| 2025-05-14 | Interim report Q1 | Event |
| 2025-05-14 | Annual General Meeting | Shareholder meeting |
| 2025-02-25 | Year-end Report 2024 | Event |
| 2024-11-27 | Quarterly Report 2024-Q3 | Event |
| 2024-08-05 | Quarterly Report 2024-Q2 | Event |
| 2024-06-19 | Annual General meeting | Shareholder meeting |
| 2024-04-29 | Quarterly Report 2024-Q1 | Event |
| 2024-02-21 | Year-end Report 2023 | Event |
| 2023-11-21 | Extra General Meeting 2023 | Shareholder meeting |
| 2023-11-09 | Quarterly Report 2023-Q3 | Event |
| 2023-08-30 | Quarterly Report 2023-Q2 | Event |
| 2023-05-26 | Annual General meeting | Shareholder meeting |